PROM1 and glioblastoma: These experimental studies also discovered that CD133+ stem cell-like GBM cells were strongly expressed in patient populations and the developing tumour vasculature. For effective targeting of GBM, the presence of Necl-5 in such major tumour components may be especially crucial.